Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
破解密碼：了解分析師對Sage Therapeutics的評論
The perception of Sage Therapeutics by financial experts is analyzed...Throughout the last three months, 17 analysts have evaluated Sage Therapeutics (NASDAQ:SAGE), offering a diverse set of opinions from bullish to bearish.
在過去三個月中，有17位分析師評估了Sage Therapeutics（NASDAQ：SAGE），提供了從看漲到看淡的各種不同意見。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.76, a high estimate of $29.00, and a low estimate of $8.00. Experiencing a 23.77% decline, the current average is now lower than the previous average price target of $25.92.
分析師評估的12個月價格目標揭示了進一步的見解，包括平均目標爲19.76美元，最高估價爲29.00美元，最低估價爲8.00美元。當前的平均值較上一個平均價格目標25.92美元下降了23.77％。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
The perception of Sage Therapeutics by financial experts is analyzed...
通過最近的分析師行動...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間